Brief: Enorama Pharma Q3 Oper Loss At SEK 4.5 Mln
20/11/2024 07:44
Nov 20 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q3 NET SALES INCREASED BY 32.27% TO KSEK 7,481
* Q3 OPERATING LOSS AMOUNTED TO KSEK -4,476
Source text: ID:nWkrjwBRd
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO